Setting the Course for Comprehensive Care Navigation in Oncology Evolent experts describe the key pieces of a scalable, comprehensive care navigation program in an article in Evidence-Based Oncology. Read Article
From every angle: Dr. Von Nguyen brings rare background to quest for high-value specialty care Chief Clinical Officer Von Nguyen brings a background in value-based payment models, artificial intelligence and health plan operations to Evolent. Read Article
Gauging the future of clinical pathways in oncology Amidst advances in therapies and technology, the core need for clinical oncology pathways remains, writes our chief medical officer. Read Article
Cancer warning to Americans as they are unclear on their family medical history Dr. Sadie Dobrozsi speaks with Newsweek about the need to identify any predisposition for cancer and undergo screening accordingly. Read Article
Repairing Fragmented Care with Value-Based Strategies Appearing on the Health Care Rounds podcast, Evolent Senior Director for Value Transformation Kamal Golla explains why value-based specialty care is primed for growth. Read Article
Cancer drugs speed to accelerated approvals, then hit the brakes in confirmatory trials Writing in Evidence-Based Oncology, Evolent’s vice president of pharmacy highlights the challenges around ensuring that “fast-track” cancer therapies deliver on their initial promise. Read Article
AI-curated clinical pathways? Not so fast. Could generative AI replace expert consensus for devising clinical guidelines? Our chief medical officer takes a look. Read Article
Value-based strategies for connecting primary and specialty care To reduce the fragmentation of care for complex conditions, we need to take on the fee-for-service models that contribute to it, says Evolent’s Dr. Vishnukamal Golla. Read Article
Dr. Sadie Dobrozsi Discusses the Future of Genetic Testing in Oncology and the Impact on Women’s Health A stronger, unified voice in our scientific community will impact the accessibility of genetic testing so that it becomes standard preventive care for everyone who qualifies — and who wants it. Read Article
Another Toxicity of Cancer Treatment Cancer treatment and the time spent traveling for care are often very time-consuming. By recognizing and working to decrease time toxicity for patients with cancer, we can lessen their burden. Read Article
Why health plans need to refresh their surgical implant strategy Barriers related to implantable devices often keep orthopedic procedures from being peformed outside the hospital. Read Article
Evolent and Careology form strategic care navigation partnership Joint offering will seek to to enable more coordinated, connected and empowered journeys for people living with cancer in the U.S. Read Press Release
The “dystopian” state of primary care Evolent's Dr. Kamal Golla speaks with the Healthcare Finance Management Association’s Voices podcast about the challenges of connecting primary and specialty care. Read Article
It's Cancer Prevention Month. Here are 11 ways to reduce your risk. Our CMO, Dr. Andrew Hertler, talks to Yahoo Life about identifying which patients need genetic testing or aggressive cancer screening, the issues surrounding prophylactic surgery, and more. Read External Article
Prophylactic Mastectomy for Patients With High-Risk Gene Mutations Dr. Andrew Hertler discussed the importance of prophylactic mastectomy for individuals carrying BRCA1, BRCA2 and other deleterious mutations. Watch Video
Pancreatic Cancer Screening, the New Guidelines, and Barriers to Care Our CMO speaks with Urban Health Today about who should get screened, the role of primary care physicians in identifying at-risk individuals, and more. Read External Article
Medicare Drug Price Negotiations and Anticipated Ripple Effects Our vice president of pharmacy explores the hard-to-predict impacts of drug price negotiations on consumers, plans and pharmaceutical companies. Read External Article
Genetic Testing in Cancer Care: Considerations for a Condition-Based Approach Two Evolent experts discuss the benefits of genetic testing in oncology in American Journal of Managed Care. Read External Article
